Sexual Health

Why young HIV+ women won’t get powerful ARV soon

1 Mins read
Reading Time: < 1 minute
ARV drugs

WAR on HIV-Aids ARV drugs 
Image: FILE

 

Young HIV-positive women will wait longer to access the powerful DTG antiviral drug.

DTG (Dolutegravir) is the preferred first-line ARV in Kenya, but not recommended for women aged 15-49 because it can deform the spines of unborn babies. Read More

Related posts
Sexual Health

Secret bacteria transferred during sex could help solve crimes where there is no DNA evidence, scientists say

1 Mins read
Reading Time: < 1 minute Scientists believe that bacteria transferred during sex could be used to help solve crimes.  Read More
60-second motivatorAIDSBusinessContraceptionCovid-19Covid19 and HIVCreativeebolaFood and Healthhealthhealth and social careHepatitisHIVImmigrationMonkey poxPersonal StoriesRelationshipsSexual HealthStartupSTIsSTIsStrategyUncategorizedVideo

Trump’s 27-year-old press secretary announces ‘no more condoms for Gaza’ in new-look briefing

1 Mins read
Reading Time: < 1 minute Donald Trump’s 27-year-old press secretary announced the US was halting shipments of condoms to Gaza during her first new-look White House briefing.  Read…
Sexual Health

Revealed: The nation where you could be most likely to catch an STI...so who comes out on top?

1 Mins read
Reading Time: < 1 minute They are the third most commonly used form of contraception in the UK, behind the Pill and the hormonal implant, official data…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.